
|Videos|January 11, 2023
Experts evaluate outcomes for men with low-grade prostate cancer undergoing RP
Author(s)Urology Times staff
"[Low-grade prostate cancer] is a really interesting field right now," says Kevin Shee, MD, PhD.
Advertisement
In this interview, Kevin Shee, MD, PhD, discusses the background key findings of the Journal of Urology study Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional Cohort. Shee is a urology resident at the University of California, San Francisco.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Trial to compare 225Ac-PSMA-617 vs 177Lu-PSMA-617 for oligorecurrent prostate cancer
2
FDA updates in urology: January 2026
3
Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC
4
FDA premarket approval sought for Signatera CDx test in MIBC
5






